Log In
BCIQ
Print this Print this
 

BMS-90168

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionAnti-CS-1antibody
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today